Megestrol acetate in pediatric oncology patients may lead to severe, symptomatic adrenal suppression-Reference-Cited by-同舟云学术

Megestrol acetate in pediatric oncology patients may lead to severe, symptomatic adrenal suppression

Published:2003-07-02 Issue:2 Volume:98 Page:397-405
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Orme Lisa M.,Bond Jodie D.,Humphrey Maureen S.,Zacharin Margaret R.,Downie Peter A.,Jamsen Kris M.,Mitchell Susan L.,Robinson Jacqueline M.,Grapsas Natalie A.,Ashley David M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference38 articles.

1. Nutritional supportive care. In: editors. Principles and practice of pediatric oncology, 3rd edition. Philadelphia: Lippincott-Raven, 1997: 1167-1181.

2. A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer

3. A prospective randomized trial to evaluate different oral dose regimens of medroxyprogesterone acetate in women with advanced breast cancer

4. Medical castration using megestrol acetate and minidose estrogen

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Megestrol-induced adrenal insufficiency in children and adolescents;MED CLIN-BARCELONA;2022

2. Megestrol-induced adrenal insufficiency in children and adolescents;Medicina Clínica (English Edition);2022-03

3. Gastroenterologische Symptome;Pädiatrische Palliativversorgung – Schmerzbehandlung und Symptomkontrolle;2022

4. Insuficiencia suprarrenal por megestrol en niños y adolescentes;Medicina Clínica;2021-05

5. iKanEat: protocol for a randomized controlled trial of megestrol as a component of a pediatric tube weaning protocol;Trials;2021-02-27